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Abstract. Basaloid squamous cell carcinoma (BSCC) is a 
rare, but distinct histologic variant of squamous cell carci-
noma in the head and neck region. It is considered to have 
a poor prognosis due to its aggressive behavior and tendency 
to metastasize. The usual sites of BSCC are the floor of the 
mouth, hypopharynx and base of the tongue, and according to 
the English-language literature its presentation in the gingiva 
is somewhat uncommon. In the current report, the unusual 
case of a 40-year-old male is presented; the patient exhibited 
a painless irregular mass in the maxillary gingiva, which 
infiltrated the maxillary sinus, as observed by computed 
tomography. Hematoxylin and eosin-stained sections revealed 
a diagnosis of BSCC with typical central necrosis in the 
cancer nests, which contained basaloid and squamous cells. 
Immunohistochemistry revealed that p63 was weakly positive, 
high molecular weight cytokeratin (CK) was focally posi-
tive, and S-100, CK7, CK14 and vimentin were negative. It 
must be noted that histopathology results may be incorrectly 
interpreted as adenoid cystic carcinoma, undifferentiated 
carcinoma and basal cell adenocarcinoma.
Introduction
Basaloid squamous cell carcinoma (BSCC) is an uncommon 
variant of squamous cell carcinoma (SCC), which was first 
described by Wain et al (1) in 1986. BSCC generally present 
in the upper aerodigestive tract, particularly in the larynx, 
hypopharynx and the base of the tongue (2). Ide et al (3) 
reported 46 cases of BSCC in the oral mucosa, where only one 
case occurred in the gingival tissues. In addition, Hirai et al (4) 
described two cases of BSCC in the mandibular gingiva. In the 
current study, an additional case of BSCC in the maxillary 
gingiva is presented and the clinical features of BSCC are 
reviewed according to the current literature. Patient provided 
written informed consent.
Case report
In October 2009, a 40-year-old male visited the outpatient 
clinic of Peking University, Shenzhen Hospital (Shenzhen, 
China) presenting with a painless irregular mass of the right 
maxillary gingiva as well as nasal obstruction following the 
presentation of the initial symptoms two months previously. 
The patient's medical history was unremarkable. The patient 
had a history of smoking for a period of 15 years (frequency, 
10/day), however, denied excessive alcohol consumption. The 
intraoral examination revealed a gray, irregular mass (size, 
3x2.5x2 cm) in the right maxillary posterior buccal gingiva, 
which elicited marginal pain on palpation. An extraoral clinical 
examination identified various palpable, mobile lymph nodes 
in the right submandibular region, measuring ~1x1x1 cm that 
were firm and non‑tender on palpation. A computed tomog-
raphy (CT) scan demonstrated a tumor, which involved the 
right maxillary sinus and infiltrated the central region of the 
hard palate (Fig. 1). The chest CT was negative for distant 
metastatic lesions. The lesion was clinically and radiologically 
classified as cT4 cNx cM0, according to the American Joint 
Committee on Cancer (AJCC) staging manual (5). The treat-
ment comprised of an extended surgical excision of the tumor, 
which involved a partial maxillectomy with mandibulectomy 
and ipsilateral functional neck dissection at levels I-III, where 
four enlarged lymph nodes were removed at level Ib.
To investigate the excised tissue, the tissues were fixed in 
10% buffered formalin and processed via the usual methods 
for paraffin embedding. The paraffin sections were stained 
with hematoxylin and eosin. Immunohistochemical staining 
was performed using the BOND‑MAX automated immunos-
tainer (Vision BioSystems, Melbourne, Australia) to further 
define the diagnosis of the tumor. The antibodies that were 
used for immunohistochemistry are presented in Table I. The 
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antigen retrieval method was heat-induced epitope retrieval 
in EDTA at an alkaline pH (pH 8.0). Adequate positive and 
negative tissue controls were used.
Microscopically, the tissues from the primary site demon-
strated that there were two cellular populations; epithelial-like 
and basaloid tumor cells. The basaloid cells formed the 
primary invasive component of the cancer nests and were 
arranged in cords, trabeculae and lobules that occasionally 
demonstrated a pseudoglandular formation. These cells exhib-
ited peripheral palisading and hyperchromatic nuclei with 
a high nucleus-cytoplasm ratio as well as a scant cytoplasm 
(Fig. 2A and B). Mitotic figures were observed within the 
nests and necrotic foci were scattered throughout the visual 
field. Components of SCC exhibiting keratinization were 
scarce, which differs to the features of conventional SCC. 
Immunohistochemically, the basaloid carcinoma cells were 
weakly positive for p63 (Fig. 2C) and focally positive for high 
molecular weight cytokeratin (CK-H; Fig. 2D), and negative 
for cytokeratin (CK)7, CK14, S-100 protein and vimentin. 
According to the clinical presentation, histopathological 
features and immunohistochemical findings, a final diagnosis 
of BSCC in the maxillary gingiva was determined. The 
surgical excision margins were healthy and the neck lymph 
node histopathology did not reveal any positive lymph nodes. 
The pathological staging of pT4 pN0 pM0 was established 
according to the AJCC staging manual.
However, the patient experienced recurrence half a year later 
and presented with a painful mass of the right cheek without 
enlarged lymph nodes on palpation. Following a failed tumor 
response to chemotherapy (dose, 16 mg pingyangmycin per 
day for seven days) and dimensional conformal radiotherapy 
(dose, 50 Gy), a second surgical intervention comprising of 
an extended resection of the neoplasm was conducted. Three 
years following treatment the patient remains free from tumor 
recurrence.
Discussion
BSCC is a rare and malignant tumor that presents in the 
head and neck region, including the oral mucosa, and has 
been defined as an aggressive and distinct variant of SCC, 
which is composed of basaloid and squamous components, 
according to the World health Organization (6). BSCC is 
particularly uncommon in the oral cavity and more so in 
the gingiva. According to Hirai et al (4), only eight cases 
of BSCC in the gingiva have been reported in the English 
literature (4,7-9), with only one case of BSCC occurring in 
the maxillary gingiva.
The clinical features of the BSCC cases that presented 
in the gingiva are reviewed and summarized in Table II. 
Two patients were female and seven were male with an 
age range of 40-79 years (mean age, 60.1 years). The most 
frequent site of origin was the mandible (n=7) followed by the 
maxilla (n=2). According to the standard tumor-node-metas-
tasis (TNM) staging, provided by the AJCC, three patients 
presented in stage I, two in stage II, three in stage III, and 
one in stage IV. All of the patients were treated using surgery, 
four underwent neck dissections and three received adjuvant 
radiotherapy. Five patients had survived at the median 
follow-up time of 56 months.
The prognosis of patients with BSCC compared 
with patients with conventional SCC remains uncertain. 
Winzenburg et al (10) first identified that distant metastases 
occurred in 52% of patients with BSCC and in 13% of 
patients with poorly differentiated SCC. Soriano et al (11) 
showed that patients with SCC were associated with notably 
higher survival rates when compared with patients with 
BSCC; furthermore, the rate of distant metastasis was six 
times higher in the cases of BSCC. However, de Sampaio 
Góes et al (12) declared that the prognosis did not differ 
between patients with BSCC of the oral cavity and those with 
conventional SCC.
Table I. Primary antibodies adopted for immunohistochemical 
staining.
Antibody Clone Source Dilution Result
p63 4A4 Santa Cruza 1:75 +
CK7 OV-TL12/30 Dakob 1:50 -
CK14 LL002 Novocastrac 1:50 -
CK-H 34βE12 Dakob 1:50 +
Vimentin V9 Dakob 1:50 -
S-100 Antiserum Dakob 1:4,000 -
aSanta Cruz Biotechnology, Inc. (Santa Cruz, CA, USA); bDako 
(Carpinteria, CA, USA); cNovocastra Laboratories (Newcastle, UK). 
CK, cytokeratin; CK-H, high molecular weight cytokeratin.
Figure 1. Computed tomography images of the basaloid squamous cell carci-
noma. (A and B) The mass invaded the maxillary sinus and the central region 
of the hard palate.
  A
  B
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The diagnosis of BSCC is currently based on histological 
criteria, including focal squamous differentiation, a basaloid 
pattern that is associated with frank invasive SCC or carci-
noma in situ. However, the histopathological diagnosis of 
BSCC is difficult to differentiate from that of adenoid cystic 
carcinoma (ACC), poorly differentiated carcinoma and basal 
cell adenocarcinoma. BSCC may easily be misdiagnosed as 
ACC, particularly when a small biopsy sample is used.
Previous studies have advocated that immunohistochem-
ical markers, including CK7, CK14, p63, CK-H, S-100 and 
vimentin aid with distinguishing BSCC from ACC (13,14).
Colleta et al (13) reported that the majority of cancer cells of 
ACC express CK7, which indicates a ductal-pattern possibly 
of salivary gland origin, while in BSCC, the basaloid cells 
exhibit positive expression for CK17 and negative expression 
for vimentin, S-100, CK7, CK8 or CK20. The p63 staining 
Table II. Reported cases of BSCC of the gingiva.
    Location  Final Follow-up
First author (ref) Year Age/gender Stage of lesion Treatment outcome period, months
Wedenberg et al (7) 1997 55/M I Maxilla S A   5
Abiko et al (8) 1998 79/F I Mandible S A  24
Yu et al (9) 2008 61/M II Mandible S + FND A 120
Yu et al (9) 2008 56/M IV Mandible S D 180
Yu et al (9) 2008 65/M III Mandible S D  2.5
Subramania et al (10) 2009 72/F III Mandible S + FND + RT A   12
Hirai et al (4) 2009 55/M II Mandible S + FND A   79
Hirai et al (4) 2009 65/M I Mandible S + RT A   60
Present case 2010 40/M III Maxilla S + FND + RT A   25
S, surgery; FND, functional neck dissection; RT, radiotherapy; A, alive; D, died.
 
Figure 2.(A) Histological sections of the basaloid squamous cell carcinoma (hematoxylin and eosin [H&E] stain; magnification, x200) displayed central 
comedo-type necrosis in the cancer nest and (B) peripheral palisading with radially arranged cells at the periphery of the lobules. (C) Diffuse tumor cells were 
weakly positive for the p63 marker, and (D) intense high molecular weight cytokeratin-positivity was observed in the membrane and cytoplasm of the cancer 
cells (B‑D: H&E stain; magnification, x200).
  A   B
  C   D
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pattern of BSCC and ACC is markedly different; the posi-
tive p63 staining is diffused in ~100% of the BSCC cancer 
cells, while ACC demonstrates a compartmentalized pattern 
within the tumor nests (15). In addition, the expression of 
CK-H is positive in BSCC cases (14). In the present case 
the immunohistochemical staining was positive for p63 and 
CK-H, and negative for S-100, vimentin, CK14 and CK7. 
Thariat et al (16) also advocated another criterion (in addition 
to the original criteria and immunohistochemical findings 
reported by Wain et al [1]) and proposed that, owing to its 
dual behavior that is marginally dependent on its association 
with the human papilloma virus (HPV), the BSCC patients 
should be systematically examined for their HPV status as 
this may determine the treatment response (17).
BSCC require aggressive multimodality treatment, 
including radical surgical excision, neck dissection, radio-
therapy and regular chemotherapy due to the high overall 
mortality rate. Although chemotherapy is recommended by 
certain authors due to the high incidence of distant metastasis 
and the relatively poor prognosis (17), a standard chemo-
therapy regimen for BSCC has not yet been established. 
Furthermore, investigation of a greater number of patients 
is required to determine the efficacy of chemotherapy for 
BSCC of the head and neck. Bonner et al (18) advocated that 
immunotherapy elicited an improved treatment effect when 
compared with radiotherapy alone and resulted in a reduced 
mortality rate.
In conclusion, the aggressive behavior of BSCC has 
been presented using a rare case of the maxillary gingiva. 
The potential difficulties of a histological diagnosis were 
discussed and the possible obstacles to an accurate diagnosis 
were emphasized. Further studies with uniform reporting are 
required in order to optimize the establishment of a diagnosis 
and define the optimum treatment strategies.
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